WEDNESDAY, Sept. 11, 2024 (HealthDay News) -- An experimental blood test could one day help identify people most likely to ...

MONDAY, Sept. 16, 2024 (HealthDay News) -- Tiny puffs from asthma inhalers could be causing big climate problems for Mother Earth, a new study warns. Each inhaler dose contains some of the most potent ...

TUESDAY, Sept. 10, 2024 (HealthDay News) -- A flare-up in COPD can be predicted through changes in a person’s voice, a new study claims. Patients’ voices become higher-pitched, more breathy or hoarse ...

The global pulmonary function testing devices market revenue was around US$ 2.0 billion in 2022 and is estimated to reach US$ 3.5 billion by 2031, growing at a compound annual growth rate (CAGR) of ...

The "Chronic Obstructive Pulmonary Disease (COPD): Epidemiology Forecast to 2033" report has been added to ResearchAndMarkets.com's offering. In the 7MM, the total prevalent cases of COPD are expected ...

GOLD COPD Report includes updated research and recommendations that reflect shifts in thinking on COPD management.

TX45 was well-tolerated with no observed immunogenicity, and demonstrated a favorable PK/PD relationship which was used to identify doses for the ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced that WINREVAIR® (sotatercept) is now authorized for use in Canada in combination with standard pulmonary arterial h ...

People in the United States die the earliest and live the sickest lives out of 10 developed countries, even though the United ...

as determined by the World Health Organization (WHO), as per the 26 August press announcement, The European approval for the subcutaneously administered therapy follows one from the US Food and ...